Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease

Wen Sheng Huang, Meei Shyuan Lee, Jiann Chyun Lin, Cheng Yu Chen, Yu Wen Yang, Shinn Zong Lin, Shiaw Pyng Wey

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Nigral dopaminergic projections to the striatum are targeted in Parkinson's disease (PD). The extent of the degeneration of the dopaminergic system in PD can be visualised by dopamine transporter imaging using single-photon emission tomography (SPET). In this study in 188 patients with PD, we analysed the image patterns and compared them with the clinical features in order to verify the usefulness of technetium-99m TRODAT-1 brain SPET in the evaluation of patients with PD. Two independent readers visually assessed SPET slices from three brain axes according to a "fine" visual scale; results were also grouped according to a "rough" visual scale. Results of both visual and semiquantitative analyses were compared among patients with different stages of PD and healthy controls. There was good agreement between the readers in the interpretation of the image patterns [kappa statistic (κ)=0.85 for the presence of PD; κ=0.88 for the rough scale and 0.81 for the fine scale]. Good concordance was obtained when visual interpretation was used to evaluate the presence of PD (sensitivity=98%, specificity=86%, κ=0.85). Semi-quantitative analyses revealed significant negative correlations between both striatal and putaminal uptake and disease severity as assessed using the Hoehn and Yahr scale (ρ=-0.89 and -0.93 respectively). An apparent decrease in striatal uptake in early PD, hardly discernible from the uptake level in advanced PD, was commonly found in visual analyses. The results suggest that both visual and semi-quantitative analyses of 99mTc TRODAT-1 SPET images reflect neurodegeneration in PD and that 99mTc-TRODAT-1 SPET represents an adequate means for evaluation of the status of patients with PD.

Original languageEnglish
Pages (from-to)155-161
Number of pages7
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume31
Issue number2
DOIs
Publication statusPublished - Feb 2004
Externally publishedYes

Fingerprint

Photons
Parkinson Disease
Tomography
Brain
Corpus Striatum
technetium Tc 99m TRODAT-1
Dopamine Plasma Membrane Transport Proteins
Substantia Nigra
Sensitivity and Specificity

Keywords

  • Tc-TRODAT-1
  • Dopamine transporter
  • Kappa statistic
  • Parkinson's disease
  • SPET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease. / Huang, Wen Sheng; Lee, Meei Shyuan; Lin, Jiann Chyun; Chen, Cheng Yu; Yang, Yu Wen; Lin, Shinn Zong; Wey, Shiaw Pyng.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, No. 2, 02.2004, p. 155-161.

Research output: Contribution to journalArticle

Huang, Wen Sheng ; Lee, Meei Shyuan ; Lin, Jiann Chyun ; Chen, Cheng Yu ; Yang, Yu Wen ; Lin, Shinn Zong ; Wey, Shiaw Pyng. / Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease. In: European Journal of Nuclear Medicine and Molecular Imaging. 2004 ; Vol. 31, No. 2. pp. 155-161.
@article{013f9942ff4d4fc88733881755068c8a,
title = "Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease",
abstract = "Nigral dopaminergic projections to the striatum are targeted in Parkinson's disease (PD). The extent of the degeneration of the dopaminergic system in PD can be visualised by dopamine transporter imaging using single-photon emission tomography (SPET). In this study in 188 patients with PD, we analysed the image patterns and compared them with the clinical features in order to verify the usefulness of technetium-99m TRODAT-1 brain SPET in the evaluation of patients with PD. Two independent readers visually assessed SPET slices from three brain axes according to a {"}fine{"} visual scale; results were also grouped according to a {"}rough{"} visual scale. Results of both visual and semiquantitative analyses were compared among patients with different stages of PD and healthy controls. There was good agreement between the readers in the interpretation of the image patterns [kappa statistic (κ)=0.85 for the presence of PD; κ=0.88 for the rough scale and 0.81 for the fine scale]. Good concordance was obtained when visual interpretation was used to evaluate the presence of PD (sensitivity=98{\%}, specificity=86{\%}, κ=0.85). Semi-quantitative analyses revealed significant negative correlations between both striatal and putaminal uptake and disease severity as assessed using the Hoehn and Yahr scale (ρ=-0.89 and -0.93 respectively). An apparent decrease in striatal uptake in early PD, hardly discernible from the uptake level in advanced PD, was commonly found in visual analyses. The results suggest that both visual and semi-quantitative analyses of 99mTc TRODAT-1 SPET images reflect neurodegeneration in PD and that 99mTc-TRODAT-1 SPET represents an adequate means for evaluation of the status of patients with PD.",
keywords = "Tc-TRODAT-1, Dopamine transporter, Kappa statistic, Parkinson's disease, SPET",
author = "Huang, {Wen Sheng} and Lee, {Meei Shyuan} and Lin, {Jiann Chyun} and Chen, {Cheng Yu} and Yang, {Yu Wen} and Lin, {Shinn Zong} and Wey, {Shiaw Pyng}",
year = "2004",
month = "2",
doi = "10.1007/s00259-003-1331-x",
language = "English",
volume = "31",
pages = "155--161",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease

AU - Huang, Wen Sheng

AU - Lee, Meei Shyuan

AU - Lin, Jiann Chyun

AU - Chen, Cheng Yu

AU - Yang, Yu Wen

AU - Lin, Shinn Zong

AU - Wey, Shiaw Pyng

PY - 2004/2

Y1 - 2004/2

N2 - Nigral dopaminergic projections to the striatum are targeted in Parkinson's disease (PD). The extent of the degeneration of the dopaminergic system in PD can be visualised by dopamine transporter imaging using single-photon emission tomography (SPET). In this study in 188 patients with PD, we analysed the image patterns and compared them with the clinical features in order to verify the usefulness of technetium-99m TRODAT-1 brain SPET in the evaluation of patients with PD. Two independent readers visually assessed SPET slices from three brain axes according to a "fine" visual scale; results were also grouped according to a "rough" visual scale. Results of both visual and semiquantitative analyses were compared among patients with different stages of PD and healthy controls. There was good agreement between the readers in the interpretation of the image patterns [kappa statistic (κ)=0.85 for the presence of PD; κ=0.88 for the rough scale and 0.81 for the fine scale]. Good concordance was obtained when visual interpretation was used to evaluate the presence of PD (sensitivity=98%, specificity=86%, κ=0.85). Semi-quantitative analyses revealed significant negative correlations between both striatal and putaminal uptake and disease severity as assessed using the Hoehn and Yahr scale (ρ=-0.89 and -0.93 respectively). An apparent decrease in striatal uptake in early PD, hardly discernible from the uptake level in advanced PD, was commonly found in visual analyses. The results suggest that both visual and semi-quantitative analyses of 99mTc TRODAT-1 SPET images reflect neurodegeneration in PD and that 99mTc-TRODAT-1 SPET represents an adequate means for evaluation of the status of patients with PD.

AB - Nigral dopaminergic projections to the striatum are targeted in Parkinson's disease (PD). The extent of the degeneration of the dopaminergic system in PD can be visualised by dopamine transporter imaging using single-photon emission tomography (SPET). In this study in 188 patients with PD, we analysed the image patterns and compared them with the clinical features in order to verify the usefulness of technetium-99m TRODAT-1 brain SPET in the evaluation of patients with PD. Two independent readers visually assessed SPET slices from three brain axes according to a "fine" visual scale; results were also grouped according to a "rough" visual scale. Results of both visual and semiquantitative analyses were compared among patients with different stages of PD and healthy controls. There was good agreement between the readers in the interpretation of the image patterns [kappa statistic (κ)=0.85 for the presence of PD; κ=0.88 for the rough scale and 0.81 for the fine scale]. Good concordance was obtained when visual interpretation was used to evaluate the presence of PD (sensitivity=98%, specificity=86%, κ=0.85). Semi-quantitative analyses revealed significant negative correlations between both striatal and putaminal uptake and disease severity as assessed using the Hoehn and Yahr scale (ρ=-0.89 and -0.93 respectively). An apparent decrease in striatal uptake in early PD, hardly discernible from the uptake level in advanced PD, was commonly found in visual analyses. The results suggest that both visual and semi-quantitative analyses of 99mTc TRODAT-1 SPET images reflect neurodegeneration in PD and that 99mTc-TRODAT-1 SPET represents an adequate means for evaluation of the status of patients with PD.

KW - Tc-TRODAT-1

KW - Dopamine transporter

KW - Kappa statistic

KW - Parkinson's disease

KW - SPET

UR - http://www.scopus.com/inward/record.url?scp=0842269091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842269091&partnerID=8YFLogxK

U2 - 10.1007/s00259-003-1331-x

DO - 10.1007/s00259-003-1331-x

M3 - Article

C2 - 15129696

AN - SCOPUS:0842269091

VL - 31

SP - 155

EP - 161

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 2

ER -